ANDA 75613, held by Invatech. Bupropion Hydrochloride.
As of Nov 15, 2026, ANDA 75613 (Bupropion Hydrochloride), held by Invatech, was first approved by FDA on Oct 10, 2000, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 10, 2000 | Original application | Approved |
| Bupropion Hydrochloride100MG · tablet;oral | Bupropion Hydrochloride | Discontinued |
| Bupropion Hydrochloride75MG · tablet;oral | Bupropion Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
